578 CD8-targeted IL-2 drives potent anti-tumor efficacy and promotes action of tumor specific vaccines

• Hussein Sultan,
• Ton Schumacher,
• Ivana Djuretic,
• Yik Andy Yeung,
• Kelly Moynihan,
• Yuang Song,
• Samuel Ameh,
• Robert Schreiber

Affiliations

Hussein Sultan

Aff483 grid.410427.40000000122849329Augusta University, Georgia Cancer Center Augusta GA USA

Ton Schumacher

Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands

Ivana Djuretic

Aff1 Celgene Cellular Therapeutics Warren NJ USA

Yik Andy Yeung

Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA

Kelly Moynihan

2MIT, Cambridge, MA, USA

Yuang Song

1Washington University School of Medicine, St. Louis, MO, USA

Samuel Ameh

1Washington University School of Medicine, St. Louis, MO, USA

Robert Schreiber

1Washington University School of Medicine, St. Louis, MO, USA